Toxicology of Industrial Compounds

178 EXTRAPOLATION OF TOXICITY DATA AND ASSESSMENT OF RISK
GARGAS, M.L., CLEWELL, H.J. and ANDERSEN, M.E., 1990, Gas uptake
inhalation techniques and the rates of metabolism of chloromethanes,
chloroethanes and chloroethylenes in the rat, Inhal. Toxicol., 2, 285–309.
GHANAYEM, B.I., 1989, Metabolic and cellular basis of 2-butoxyethanol-induced
hemolytic anemia in rats and assessment of human risk in vitro, Biochem.
Pharmacol., 8, 1679–84.
GHANAYEM, B.I., BURKA, L.T. and METTHEWS, H.B., 1987, Metabolic basis
of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol
and aldehyde dehydrogenases, J. Pharmacol. Exp. Therap., 242, 222–31.
HALLENBECK, W.H., 1993, Quantitative Risk Assessment of Environmental and
Occupational Health, Chelsea, MI: Lewis Publisher, Inc.
HORTON, V.L., HIGUCHI, M.A. and RICKERT, D.E., 1992, Physiologically
based pharmacokinetic model for methanol in rats, monkeys and humans,
Toxicol. Appl. Pharmacol., 117, 26–36.
JOHANSON, G., 1986, Physiologically-based pharmocokinetic modeling of
inhaled 2-butoxyethanol in man, Toxicol. Lett., 34, 23–31.
JOHANSON, G. and FILSER, J.G., 1993, A physiologically based pharmacokinetic
model for butadiene and its metabolite butadiene monoxide in rat and mouse
and its significance for risk extrapolation, Arch. Toxicol., 67, 151–63.
KRISHNAN, K., GARGAS, M.L., FENNELL, T.R. and ANDERSEN, M.E., 1992,
A physiologically based description of ethylene oxide dosimetry in the rat,
Toxicol. Ind. Health, 8, 121–40.
LEHMAN, A.J. and FITZHUGH, O.G., 1954, 100-fold margin of safety, Assoc.
Food Drug Off. US. Bull., 18, 33–5.
LEWIS, S.C., LYNCH, J.R. and NIKIFOROV, A.I., 1990, A new approach to
deriving exposure guidelines from ‘no-observed-adverse-effect levels’, Regul.
Toxicol. Pharmacol., 11, 314–30.
MOOLGAVKER, S.H., DEWANJI, A. and VENZON, D.J., 1988, A stochastic
two-stage model for cancer risk assessment. I. The hazard function and the
probability of tumor, Risk Anal., 8, 383–92.
PARK, C.N. and HAWKINS, N.C., 1993, An overview of cancer risk assessment,
Toxicology Methods, 3, 63–86.
PORTIER, C.J. and KAPLAN, N.L., 1989, Variability of safe dose estimates when
using complicated models of the carcinogenic process. A case study: methylene
chloride, Toxicol. Appl. Pharmacol, 13, 533–44.
POTTER, D.W. and TRAN, T.-B., 1993, Apparent rates of glutathione turnover in
rat tissues, Toxicol. Appl. Pharmacol., 120, 186–92.
RAMSEY, J.C. and ANDERSEN, M.E., 1984, A physiologically based description
of the inhalation pharmacokinetics of styrene in rats and humans, Toxicol.
Appl. Pharmacol., 73, 159–75.
REITZ, R.H., MENDRALA, A.L., PARK, C.N., ANDERSEN, M.E. and
GUENGERICH, F.P., 1988, Incorporation of in vitro enzyme data into the
physiologically based pharmacokinetic model for methylene chloride:
implications for risk assessment, Toxicol. Lett., 43, 97–116.
REITZ, R.H., MCCROSKY, P.S., PARK, C.N., ANDERSEN, M.E. and GARGAS,
M.L., 1990a, Development of a physiologically based pharmacokinetic model
for risk assessment with 1,4-dioxane, Toxicol. Appl. Pharmacol, 105, 37–54.